Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -0.07% | 67.51 | 1.0% | $1047.35m | |
| BIIB | Biogen, Inc. | 3.00% | 343.00 | 1.5% | $720.34m | |
| AMGN | Amgen, Inc. | -0.62% | 222.09 | 1.3% | $585.61m | |
| ILMN | Illumina, Inc. | 2.59% | 298.92 | 3.5% | $440.19m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.45% | 397.74 | 2.6% | $385.35m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.74% | 242.01 | 1.9% | $346.26m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.00% | 102.56 | 2.0% | $208.61m | |
| EXAS | EXACT Sciences Corp. | 3.61% | 98.18 | 24.0% | $165.42m | |
| A | Agilent Technologies, Inc. | 0.41% | 86.19 | 1.6% | $152.04m | |
| SGEN | Seattle Genetics, Inc. | -0.13% | 118.07 | 6.1% | $116.25m | |
| MRNA | Moderna, Inc. | 0.74% | 19.14 | 0.0% | $112.10m | |
| INCY | Incyte Corp. | -0.57% | 78.00 | 2.5% | $100.64m | |
| XLRN | Acceleron Pharma, Inc. | -0.48% | 93.66 | 6.1% | $99.78m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.31% | 125.42 | 14.6% | $97.24m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.87% | 89.01 | 4.3% | $93.97m |
Company Profile
Inmune Bio, Inc. is a clinical stage biotechnology company, which develops immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. Its products include INKMUNE and INB03. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.